Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

Transcriptional regulation of CD4 gene expression by T cell factor-1/beta-catenin pathway.

Huang Z, Xie H, Ioannidis V, Held W, Clevers H, Sadim MS, Sun Z.

J Immunol. 2006 Apr 15;176(8):4880-7.

2.

Stabilized beta-catenin extends thymocyte survival by up-regulating Bcl-xL.

Xie H, Huang Z, Sadim MS, Sun Z.

J Immunol. 2005 Dec 15;175(12):7981-8.

3.

The beta-catenin--TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival.

Ioannidis V, Beermann F, Clevers H, Held W.

Nat Immunol. 2001 Aug;2(8):691-7.

PMID:
11477404
4.

Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.

Grueter B, Petter M, Egawa T, Laule-Kilian K, Aldrian CJ, Wuerch A, Ludwig Y, Fukuyama H, Wardemann H, Waldschuetz R, Möröy T, Taniuchi I, Steimle V, Littman DR, Ehlers M.

J Immunol. 2005 Aug 1;175(3):1694-705. Erratum in: J Immunol. 2005 Nov 1;175(9):6238.

5.

Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.

Matsuzaki E, Takahashi-Yanaga F, Miwa Y, Hirata M, Watanabe Y, Sato N, Morimoto S, Hirofuji T, Maeda K, Sasaguri T.

J Bone Miner Res. 2006 Aug;21(8):1307-16.

6.

STMN2 is a novel target of beta-catenin/TCF-mediated transcription in human hepatoma cells.

Lee HS, Lee DC, Park MH, Yang SJ, Lee JJ, Kim DM, Jang Y, Lee JH, Choi JY, Kang YK, Kim DI, Park KC, Kim SY, Yoo HS, Choi EJ, Yeom YI.

Biochem Biophys Res Commun. 2006 Jul 7;345(3):1059-67. Epub 2006 May 11.

PMID:
16712787
8.

Regulation of thymocyte survival by transcriptional coactivators.

Xie H, Huang Z, Wang R, Sun Z.

Crit Rev Immunol. 2006;26(6):475-86. Review.

PMID:
17341189
9.

TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent.

Vietor I, Kurzbauer R, Brosch G, Huber LA.

J Biol Chem. 2005 Dec 2;280(48):39795-801. Epub 2005 Oct 3.

10.

Initiation and limitation of Ly-49A NK cell receptor acquisition by T cell factor-1.

Ioannidis V, Kunz B, Tanamachi DM, Scarpellino L, Held W.

J Immunol. 2003 Jul 15;171(2):769-75.

11.

Morpholino antisense oligonucleotide-mediated gene knockdown during thymocyte development reveals role for Runx3 transcription factor in CD4 silencing during development of CD4-/CD8+ thymocytes.

Ehlers M, Laule-Kilian K, Petter M, Aldrian CJ, Grueter B, Würch A, Yoshida N, Watanabe T, Satake M, Steimle V.

J Immunol. 2003 Oct 1;171(7):3594-604.

12.

Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.

Tomita H, Yamada Y, Oyama T, Hata K, Hirose Y, Hara A, Kunisada T, Sugiyama Y, Adachi Y, Linhart H, Mori H.

Cancer Res. 2007 May 1;67(9):4079-87.

13.

Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL.

Manicassamy S, Gupta S, Huang Z, Sun Z.

J Immunol. 2006 Jun 1;176(11):6709-16.

14.

E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.

Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF.

Mol Cell Biol. 2007 Nov;27(21):7703-17. Epub 2007 Sep 4.

15.

Characterization of an intronless CD4 minigene expressed in mature CD4 and CD8 T cells, but not expressed in immature thymocytes.

Salmon P, Boyer O, Lorès P, Jami J, Klatzmann D.

J Immunol. 1996 Mar 1;156(5):1873-9.

PMID:
8596039
16.
17.

beta-Catenin expression enhances generation of mature thymocytes.

Mulroy T, Xu Y, Sen JM.

Int Immunol. 2003 Dec;15(12):1485-94.

PMID:
14645157
18.

Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.

Gustavson MD, Crawford HC, Fingleton B, Matrisian LM.

Mol Carcinog. 2004 Nov;41(3):125-39.

PMID:
15457508
19.

Intracellular expression of the T-cell factor-1 RNA aptamer as an intramer.

Choi KH, Park MW, Lee SY, Jeon MY, Kim MY, Lee HK, Yu J, Kim HJ, Han K, Lee H, Park K, Park WJ, Jeong S.

Mol Cancer Ther. 2006 Sep;5(9):2428-34.

20.

Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II.

Bruniquel D, Borie N, Hannier S, Triebel F.

Immunogenetics. 1998 Jul;48(2):116-24.

PMID:
9634475

Supplemental Content

Support Center